- Home
- / Takara Bio
Takara Bio
Stock Price
¥1 K
2024-10-29
Market Capitalization
¥122.8 B
2024-10-29
Revenue
¥45 B
FY, 2025
Takara Bio Summary
Company Summary
- Overview
- Takara Bio is a company that develops genetic engineering technologies. Its products include research reagents, gene medicines, and scientific instruments.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Kusatsu, JP | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Kusatsu, Shiga HQ
Japan
Takara Bio Financials
Summary Financials
- Revenue (Q3, 2026)
- ¥28.4B
- Gross profit (Q3, 2026)
- ¥18.0B
- Net income (Q3, 2026)
- (¥9.6B)
- Cash (Q3, 2026)
- ¥19.8B
- EBIT (Q3, 2026)
- (¥8.6B)
- Enterprise value
- $113.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026